Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Xin Wu

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
British Journal of Haematology|March 28, 2019
S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemiaJing Zhang, Wen-Yi Lu, Jia-Min Zhang, et al.
British Journal of Haematology|May 26, 2025
Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemiaLi-Xin Wu, Ming-Yue Liao, Ming-Yue Zhao, et al.
British Journal of Haematology|February 19, 2020
DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemiaJia-Min Zhang, Yan Xu, Robert P Gale, et al.
Biomolecules & Biomedicine|May 15, 2023
CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemiaLei-Ming Cao, Ya-Lan Zhou, Robert Peter Gale, et al.
British Journal of Haematology|February 28, 2020
Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD)Ya-Lan Zhou, Li-Xin Wu, Robert Peter Gale, et al.
Cancer Letters|July 5, 2024
Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemiaNan Yan, Zi-Long Wang, Xiao-Juan Wang, et al.
Frontiers in Oncology|September 6, 2021
Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Mutations Based on a Multi-Gene Panel and Nomogram ModelLi-Xin Wu, Hao Jiang, Ying-Jun Chang, et al.
International Journal of Cancer|May 26, 2025
Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world studyYu-Qian Sun, Li-Xin Wu, Yi-Cheng Zhang, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
British Journal of Haematology|March 28, 2019
S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemiaJing Zhang, Wen-Yi Lu, Jia-Min Zhang, et al.
British Journal of Haematology|May 26, 2025
Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemiaLi-Xin Wu, Ming-Yue Liao, Ming-Yue Zhao, et al.
British Journal of Haematology|February 19, 2020
DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemiaJia-Min Zhang, Yan Xu, Robert P Gale, et al.
Biomolecules & Biomedicine|May 15, 2023
CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemiaLei-Ming Cao, Ya-Lan Zhou, Robert Peter Gale, et al.
British Journal of Haematology|February 28, 2020
Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD)Ya-Lan Zhou, Li-Xin Wu, Robert Peter Gale, et al.
Cancer Letters|July 5, 2024
Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemiaNan Yan, Zi-Long Wang, Xiao-Juan Wang, et al.
Frontiers in Oncology|September 6, 2021
Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Mutations Based on a Multi-Gene Panel and Nomogram ModelLi-Xin Wu, Hao Jiang, Ying-Jun Chang, et al.
International Journal of Cancer|May 26, 2025
Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world studyYu-Qian Sun, Li-Xin Wu, Yi-Cheng Zhang, et al.
Pageof 6